CLITORIA TERNATEA: PHYTOCHEMICAL PROFILE, PHARMACOLOGICAL POTENTIAL, AND EMERGING NUTRACEUTICAL APPLICATIONS

Rohan Raut*, Sanika Mote*

Clitoria ternatea, commonly known as butterfly pea, is a perennial legume rich in bioactive compounds with significant therapeutic promise. This review article explores its phytochemical composition, diverse pharmacological activities, and rising role in nutraceuticals, highlighting opportunities for functional food development.Clitoria ternatea contains key phytochemicals such as anthocyanins (e.g., ternatins), flavonoids, phenolic compounds, alkaloids, saponins, and tannins across its flowers, leaves, seeds, and roots. The plant exhibits antioxidant, antidiabetic, hepatoprotective, anticancer, anti-obesity, and neuroprotective activities, validated in preclinical models. Flower extracts show antiproliferative effects on cancer cells via apoptosis induction and inhibit enzymes like acetylcholinesterase for cognitive benefits. Clinical evidence supports its role in reducing oxidative stress in type 2 diabetes patient. Emerging uses include natural food colorants, functional beverages, and active packaging due to its color stability and antimicrobial properties. Its safety profile and clean-label appeal position it for supplements targeting metabolic and liver health. Further human trials are needed to optimize dosages and formulations.